Pulmonary arterial hypertension--the primary pulmonary hypertension syndromes.
D000959:Antihypertensive Agents / Q000627:therapeutic use; D000077300:Bosentan; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D016232:Endothelins / Q000037:antagonists & inhibitors; D011464:Epoprostenol / Q000031:analogs & derivatives; D006801:Humans; D006976:Hypertension, Pulmonary / Q000145:classification / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D013449:Sulfonamides / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D016232:Endothelins; D013449:Sulfonamides; D014665:Vasodilator Agents; D011464:Epoprostenol; D000077300:Bosentan